Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
Kim H.T. Paraiso(Molecular Oncology (United States)), Keiran S.M. Smalley(Moffitt Cancer Center)
Cited by 313
Related Papers
PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression
|Cancer Research|2011|546
Dysregulation of Claudin-7 Leads to Loss of E-Cadherin Expression and the Increased Invasion of Esophageal Squamous Cell Carcinoma Cells
|American Journal Of Pathology|2007|134
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels
|British Journal of Cancer|2007|105
Identification of a Novel Subgroup of Melanomas with KIT/Cyclin-Dependent Kinase-4 Overexpression
|Cancer Research|2008|97
Farnesyl transferase inhibitor SCH66336 is cytostatic, pro‐apoptotic and enhances chemosensitivity to cisplatin in melanoma cells
|International Journal of Cancer|2003|94